222 related articles for article (PubMed ID: 34118772)
61. Prognostic factors associated with overall survival in patients with oral cavity squamous cell carcinoma.
Oliveira LL; Bergmann A; Melo AC; Thuler LC
Med Oral Patol Oral Cir Bucal; 2020 Jul; 25(4):e523-e531. PubMed ID: 32520923
[TBL] [Abstract][Full Text] [Related]
62. The mutational spectrum in whole exon of p53 in oral squamous cell carcinoma and its clinical implications.
Hyodo T; Kuribayashi N; Fukumoto C; Komiyama Y; Shiraishi R; Kamimura R; Sawatani Y; Yaguchi E; Hasegawa T; Izumi S; Wakui T; Nakashiro KI; Uchida D; Kawamata H
Sci Rep; 2022 Dec; 12(1):21695. PubMed ID: 36522371
[TBL] [Abstract][Full Text] [Related]
63. Mutational spectrum of tobacco associated oral squamous carcinoma and its therapeutic significance.
Batta N; Pandey M
World J Surg Oncol; 2019 Nov; 17(1):198. PubMed ID: 31775759
[TBL] [Abstract][Full Text] [Related]
64. Noninvasive genomic profiling of somatic mutations in oral cavity cancers.
Xi Y; Negrao MV; Akagi K; Xiao W; Jiang B; Warner SC; Dunn JD; Wang J; Symer DE; Gillison ML
Oral Oncol; 2023 May; 140():106372. PubMed ID: 37004423
[TBL] [Abstract][Full Text] [Related]
65. Combination of Tumor Mutational Burden and Specific Gene Mutations Stratifies Outcome to Immunotherapy Across Recurrent and Metastatic Head and Neck Squamous Cell Carcinoma.
Peng YP; Wang R; Liu QD; Xu XW; Wei W; Huang XT; Peng XM; Liu ZG
Front Genet; 2021; 12():756506. PubMed ID: 34868231
[No Abstract] [Full Text] [Related]
66. Tumor thickness as an independent risk factor of early recurrence in oral cavity squamous cell carcinoma.
Pinto FR; de Matos LL; Palermo FC; Kulcsar MA; Cavalheiro BG; de Mello ES; Alves VA; Cernea CR; Brandão LG
Eur Arch Otorhinolaryngol; 2014 Jun; 271(6):1747-54. PubMed ID: 24071858
[TBL] [Abstract][Full Text] [Related]
67. Role of EGFR as prognostic factor in head and neck cancer patients treated with surgery and postoperative radiotherapy: proposal of a new approach behind the EGFR overexpression.
Alterio D; Marvaso G; Maffini F; Gandini S; Chiocca S; Ferrari A; Preda L; Rocca MC; Lepanto D; Fodor C; Volpe S; Dicuonzo S; Laudati A; Giugliano G; Ansarin M; Jereczek-Fossa BA
Med Oncol; 2017 Jun; 34(6):107. PubMed ID: 28452036
[TBL] [Abstract][Full Text] [Related]
68. Identification of Prognostic and Tumor Microenvironment by Shelterin Complex-Related Signatures in Oral Squamous Cell Carcinoma.
Zhang S; Yu H; Li J; Zhao L; Tan L; Song Q; Sun C
Oxid Med Cell Longev; 2022; 2022():6849304. PubMed ID: 35757510
[TBL] [Abstract][Full Text] [Related]
69. Distinct pattern of TP53 mutations in human immunodeficiency virus-related head and neck squamous cell carcinoma.
Gleber-Netto FO; Zhao M; Trivedi S; Wang J; Jasser S; McDowell C; Kadara H; Zhang J; Wang J; William WN; Lee JJ; Nguyen ML; Pai SI; Walline HM; Shin DM; Ferris RL; Carey TE; Myers JN; Pickering CR;
Cancer; 2018 Jan; 124(1):84-94. PubMed ID: 29053175
[TBL] [Abstract][Full Text] [Related]
70. The prognostic value of TMB and the relationship between TMB and immune infiltration in head and neck squamous cell carcinoma: A gene expression-based study.
Zhang L; Li B; Peng Y; Wu F; Li Q; Lin Z; Xie S; Xiao L; Lin X; Ou Z; Cai T; Rong H; Fan S; Li J
Oral Oncol; 2020 Nov; 110():104943. PubMed ID: 32919362
[TBL] [Abstract][Full Text] [Related]
71. Multi-omics analysis of tumor mutational burden combined with prognostic assessment in epithelial ovarian cancer based on TCGA database.
Liu J; Xu W; Li S; Sun R; Cheng W
Int J Med Sci; 2020; 17(18):3200-3213. PubMed ID: 33173439
[No Abstract] [Full Text] [Related]
72. Pretreatment albumin level predicts survival in head and neck squamous cell carcinoma.
Lim WS; Roh JL; Kim SB; Choi SH; Nam SY; Kim SY
Laryngoscope; 2017 Dec; 127(12):E437-E442. PubMed ID: 28561532
[TBL] [Abstract][Full Text] [Related]
73. Prognostic value of circulating biomarker score in advanced-stage head and neck squamous cell carcinoma.
Park MJ; Roh JL; Kim SB; Choi SH; Nam SY; Kim SY
Eur J Cancer; 2018 Mar; 92():69-76. PubMed ID: 29428866
[TBL] [Abstract][Full Text] [Related]
74. Prognostic impact of perineural invasion and lymphovascular invasion in advanced stage oral squamous cell carcinoma.
Jardim JF; Francisco AL; Gondak R; Damascena A; Kowalski LP
Int J Oral Maxillofac Surg; 2015 Jan; 44(1):23-8. PubMed ID: 25457832
[TBL] [Abstract][Full Text] [Related]
75. A combined analysis of maximum standardized uptake value on FDG-PET, genetic markers, and clinicopathological risk factors in the prognostic stratification of patients with resected oral cavity squamous cell carcinoma.
Liao CT; Hsieh CH; Fan WL; Ng SH; Cheng NM; Lee LY; Hsueh C; Lin CY; Fan KH; Wang HM; Lin CH; Tsao CK; Kang CJ; Fang TJ; Huang SF; Chang KP; Lee LA; Fang KH; Wang YC; Yang LY; Yen TC
Eur J Nucl Med Mol Imaging; 2020 Jan; 47(1):84-93. PubMed ID: 31388722
[TBL] [Abstract][Full Text] [Related]
76. Overexpression of caldesmon is associated with lymph node metastasis and poorer prognosis in patients with oral cavity squamous cell carcinoma.
Chang KP; Wang CL; Kao HK; Liang Y; Liu SC; Huang LL; Hseuh C; Hsieh YJ; Chien KY; Chang YS; Yu JS; Chi LM
Cancer; 2013 Nov; 119(22):4003-11. PubMed ID: 23963810
[TBL] [Abstract][Full Text] [Related]
77. Mutational Characterization and Potential Prognostic Biomarkers of Chinese Patients with Esophageal Squamous Cell Carcinoma.
Zhang N; Shi J; Shi X; Chen W; Liu J
Onco Targets Ther; 2020; 13():12797-12809. PubMed ID: 33363385
[TBL] [Abstract][Full Text] [Related]
78. Ultrasensitive detection of tumor-specific mutations in saliva of patients with oral cavity squamous cell carcinoma.
Shanmugam A; Hariharan AK; Hasina R; Nair JR; Katragadda S; Irusappan S; Ravichandran A; Veeramachaneni V; Bettadapura R; Bhati M; Ramaswamy V; Rao VUS; Bagadia RK; Manjunath A; Manjunath NML; Solomon MC; Maji S; Bahadur U; Bettegowda C; Papadopoulos N; Lingen MW; Hariharan R; Gupta V; Agrawal N; Izumchenko E
Cancer; 2021 May; 127(10):1576-1589. PubMed ID: 33405231
[TBL] [Abstract][Full Text] [Related]
79. TERT promoter hotspot mutations and their relationship with TERT levels and telomere erosion in patients with head and neck squamous cell carcinoma.
Boscolo-Rizzo P; Giunco S; Rampazzo E; Brutti M; Spinato G; Menegaldo A; Stellin M; Mantovani M; Bandolin L; Rossi M; Del Mistro A; Tirelli G; Dei Tos AP; Guerriero A; Niero M; Da Mosto MC; Polesel J; De Rossi A
J Cancer Res Clin Oncol; 2020 Feb; 146(2):381-389. PubMed ID: 31960186
[TBL] [Abstract][Full Text] [Related]
80. Definitive (chemo)radiotherapy is a curative alternative for standard of care in advanced stage squamous cell carcinoma of the oral cavity.
Elbers JBW; Al-Mamgani A; Paping D; van den Brekel MWM; Jóźwiak K; de Boer JP; Karakullukcu B; Verheij M; Zuur CL
Oral Oncol; 2017 Dec; 75():163-168. PubMed ID: 29224815
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
